Abstract
BackgroundMany studies reported high prevalence of antiphospholipid antibodies (aPL) in patients with COVID-19 raising questions about its true prevalence and its clinical impact on the disease course.MethodsWe conducted a meta-analysis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have